newsfilter
← Latest News
Business Wire·

TriSalus Life Sciences Reports First Quarter 2025 Results and Provides Updated 2025 Guidance

Company delivers 42% revenue growth year-over-year and strengthens balance sheet with $22 million gross proceeds from recent private placement Expands commercial footprint, and invests further in new applications for